We are live on ! Find out more
GRNA

GreenLight Biosciences Holdings, PBC Common Stock

Delisted

GRNA was delisted on the 21st of July, 2023.

39 hedge funds and large institutions have $280M invested in GreenLight Biosciences Holdings, PBC Common Stock in 2022 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more funds holding in top 10

Funds holding in top 10: 16 (+5)

61% more capital invested

Capital invested by funds: $173M → $280M (+$106M)

33% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 6

43% less funds holding

Funds holding: 6839 (-29)

51% less first-time investments, than exits

New positions opened: 28 | Existing positions closed: 57

Holders
39
Holders Change
-29
Holders Change %
-42.65%
% of All Funds
0.62%
Holding in Top 10
6
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+500%
% of All Funds
0.09%
New
28
Increased
4
Reduced
6
Closed
57
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
51
Saba Capital Management
New York
-$3.74M -376,991 Closed
Alyeska Investment Group
52
Alyeska Investment Group
Illinois
-$3.47M -350,000 Closed
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
53
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Ontario, Canada
-$3.22M -325,000 Closed
WCMNY
54
Westchester Capital Management (New York)
New York
-$3M -302,939 Closed
AAA
55
Affinity Asset Advisors
New York
-$2.98M -300,000 Closed
AC
56
Ayrton Capital
Connecticut
-$2.98M -300,000 Closed
IPCP
57
Iron Park Capital Partners
New York
-$2.65M -267,201 Closed
Bank of Montreal
58
Bank of Montreal
Ontario, Canada
-$2.58M -259,806 Closed
UOC
59
UBS O'Connor
Illinois
-$2.56M -258,084 Closed
USPCM
60
Union Square Park Capital Management
New York
-$2.52M -253,770 Closed
WA
61
Whitebox Advisors
Minnesota
-$2.19M -220,668 Closed
CCA
62
Castle Creek Arbitrage
Colorado
-$1.98M -200,000 Closed
MI
63
MMCAP International
Cayman Islands
-$1.98M -200,000 Closed
TIM
64
Timelo Investment Management
Ontario, Canada
-$1.98M -200,000 Closed
AA
65
AQR Arbitrage
Connecticut
-$1.86M -187,716 Closed
CL
66
CSS LLC
Illinois
-$1.62M -163,380 Closed
WRBC
67
W.R. Berkley Corp
Connecticut
-$1.55M -156,299 Closed
TCM
68
Tenor Capital Management
New York
-$1.45M -146,300 Closed
Nomura Holdings
69
Nomura Holdings
Japan
-$1.3M -131,500 Closed
YCM
70
Yakira Capital Management
Connecticut
-$1.24M -125,000 Closed
VI
71
Vestcor Inc
New Brunswick, Canada
-$1.12M -112,500 Closed
Toronto Dominion Bank
72
Toronto Dominion Bank
Ontario, Canada
-$1.03M -104,086 Closed
LCM
73
Lynwood Capital Management
Ontario, Canada
-$1.01M -102,076 Closed
SSA
74
Schonfeld Strategic Advisors
New York
-$927K -93,428 Closed
RCM
75
Radcliffe Capital Management
Pennsylvania
-$890K -89,754 Closed

GRNA Hedge Fund Activity: Q1 2022 in Review

39 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in GreenLight Biosciences Holdings, PBC Common Stock (GRNA) for Q1 2022, worth a combined $280M — up 61% from $173M a quarter earlier.

Sellers outnumbered buyers: 57 funds closed out of GRNA and 28 opened new positions — a net loss of 29 holders — while 6 trimmed existing stakes and 4 added.

The largest buyer was Cormorant Asset Management, opening a new position worth an estimated $60.1M. The largest seller was Highbridge Capital Management, exiting entirely with an estimated $18.9M sold.

  • 39 institutional investors held GreenLight Biosciences Holdings, PBC Common Stock (GRNA) as of Q1 2022, down from 68 in Q4 2021.
  • Funds reported $280M of GreenLight Biosciences Holdings, PBC Common Stock stock for Q1 2022, up 61% quarter-over-quarter.
  • 28 funds opened new GreenLight Biosciences Holdings, PBC Common Stock positions in Q1 2022 and 57 closed out, a net change of -29 holders.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock buyer in Q1 2022 was Cormorant Asset Management, an estimated $60.1M added.
  • The largest GreenLight Biosciences Holdings, PBC Common Stock seller in Q1 2022 was Highbridge Capital Management, an estimated $18.9M sold.

Based on aggregated 13F filings for Q1 2022.